HSAI and JL among Consumer Discretionary movers
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Mar 06 2024
0mins
Should l Buy CREV?
Source: SeekingAlpha
- Gainers: Carbon Revolution Public Ltd. Co. (CREV) +31%, Dada Nexus Ltd (DADA) +30%, Hesai Group (HSAI) +19%, JD.com (JD) +18%, EVgo (EVGO) +17%
- Losers: Foot Locker (FL) -30%, J-Long Group Ltd (JL) -21%, Nordstrom (JWN) -15%, Thor Industries (THO) -11%, Volcon (VLCN) -11%
- S&P 500 Consumer Discretionary Sector up by 0.21% to 1455.77
- Automobiles & Components down by 1% to 104.84
- Retailing, contributing 52% to the index, is up by 0.4% to 4385.43
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy CREV?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on CREV
About CREV
Carbon Revolution plc is a global technology company, which is an original equipment manufacturer (OEM) supplier that develops and supplies lightweight carbon fiber wheels to the global automotive industry. The Company commercializes and industrializes the supply of lightweight carbon fiber wheels to the automotive industry. It designs and manufactures lightweight wheels for cars and SUVs in the high-performance, premium, and luxury segments for automotive brands. The Company focuses on developing a technology business that supplies its lightweight wheel products to automotive manufacturers globally. Its lightweight wheel technology aims to improve vehicle performance, efficiency, and handling, contributing to drivability, fuel efficiency, range extension, and reduced lap times. Its technology applies to automotive, original equipment manufacturing (OEM), electric vehicles, aerospace, motorsport, and heavy vehicles.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
U.S. Stocks Rise, AutoNation Shares Surge
- Market Performance: U.S. stocks traded higher midway through trading, with the S&P 500 gaining approximately 1.6%, the Dow rising 2.01% to 49,891.59, and the NASDAQ climbing 1.84% to 22,954.50, indicating a positive market sentiment and increased investor confidence.
- Sector Dynamics: Information technology shares gained 2.5% on Friday, while communication services stocks fell by 2%, reflecting a preference for tech stocks and concerns over the communication sector, which may impact future performance of related companies.
- AutoNation Earnings: Shares of AutoNation, Inc. (NYSE:AN) surged over 7% after posting fourth-quarter results, reporting adjusted earnings per share of $5.08, a 2% year-over-year increase that beat analyst expectations of $4.85, despite sales of $6.929 billion missing the consensus estimate of $7.200 billion, showcasing the company's resilience in profitability.
- Economic Indicators: The U.S. Manheim Used Vehicle Value Index rose 2.4% month-over-month in January, while the University of Michigan's consumer sentiment index increased by 0.9 points to 57.3, exceeding market estimates of 55, indicating a rebound in consumer confidence that could positively influence future spending.
See More
U.S. Stocks Rise in Morning Trading, Dow Jones Up Over 600 Points
- Strong Dow Performance: The Dow Jones index surged over 600 points on Friday, gaining 1.29% to close at 49,537.77, indicating a robust market rebound that may attract more investor interest.
- NASDAQ and S&P 500 Rise: The NASDAQ climbed 0.97% to 22,759.56, while the S&P 500 rose 1.02% to 6,867.68, reflecting a recovery trend in tech and other sectors, thereby boosting market confidence.
- Amazon's Earnings Impact Stock Price: Amazon.com Inc. (NASDAQ:AMZN) shares fell around 9% on Friday despite reporting fourth-quarter net sales of $213.39 billion, a 14% year-over-year increase; however, its earnings per share of $1.95 missed the consensus estimate of $1.97, leading to diminished investor confidence.
- Commodity Market Fluctuations: Oil prices dipped 0.3% to $63.08, while gold rose 1.6% to $4,969.10, indicating increased demand for safe-haven assets, and copper saw a slight increase of 0.4% to $5.8460, reflecting stable industrial demand.
See More
Carbon Revolution Faces Nasdaq Delisting
- Delisting Notification: Carbon Revolution plc received a notification from Nasdaq indicating that it will be delisted due to non-compliance with minimum shareholders' equity and failure to file its annual report, with trading suspension effective February 9, 2026, severely impacting the company's financing capabilities and market trust.
- Market Value Deficiency: The company's Market Value of Publicly Held Shares fell below $15 million over the last 30 trading days, and although there is a 180-day cure period, this opportunity is rendered moot by the delisting decision, likely leading to further declines in investor confidence.
- Compliance Failures: The company failed to provide sufficient information by January 30, 2026, to demonstrate its ability to complete a strategic transaction by May 5, 2026, indicating significant management shortcomings in compliance and financial transparency, which may hinder future financing and business development.
- Market Reaction: The delisting news is expected to severely impact Carbon Revolution's stock price, raising investor concerns about its future profitability and market position, further exacerbating the financial pressures the company faces.
See More
Ultragenyx Shares Plunge 42% Following Phase 3 Study Failures for Setrusumab
- Stock Plunge: Ultragenyx Pharmaceutical's shares fell sharply by 42% to $19.84 on Monday, primarily due to the failure of its Phase 3 Orbit and Cosmic studies for setrusumab (UX143) in Osteogenesis Imperfecta, leading to a significant decline in market confidence.
- Clinical Trial Failure: The results from Mereo BioPharma and Ultragenyx indicated that setrusumab did not achieve statistical significance in reducing the annualized clinical fracture rate, which not only impacts the company's short-term financial performance but may also have long-term negative implications for its future R&D investments and market competitiveness.
- Severe Market Reaction: The disappointing trial results raised investor concerns about Ultragenyx's future prospects, resulting in a substantial decrease in its market capitalization, reflecting the high sensitivity of investors to the success or failure of clinical trials in the biopharmaceutical sector.
- Industry Impact: Ultragenyx's failure could have a ripple effect across the biopharmaceutical industry, particularly in the bone metabolism disease space, as investors may adopt a more cautious approach towards similar product developments, potentially affecting financing and R&D strategies of related companies.
See More
Planet Labs Shares Rise Approximately 16%; Check Out 20 Stocks Making Moves in Premarket Trading
Planet Labs Performance: Planet Labs PBC shares surged 16.4% to $15.15 in pre-market trading after reporting third-quarter revenue of $81.25 million, exceeding analyst expectations, and raising its FY26 sales guidance.
Other Gainers: Several stocks saw significant pre-market gains, including Agape ATP Corporation (+152.3%), WORK Medical Technology Group (+38.4%), and Galaxy Payroll Group (+37.8%).
Notable Losers: Stocks that experienced sharp declines include Kaival Brands (-40%), Beasley Broadcast Group (-35.3%), and Oxford Industries (-25.6%) after reporting disappointing financial results.
Market Overview: The pre-market trading session showed a mix of gains and losses across various stocks, with notable movements influenced by recent earnings reports and guidance updates.
See More
Most Active Stocks in Pre-Market on October 17, 2025: BITF, SQQQ, ARTV, IONZ, TSLL, CREV, NIO, GWH, BBAI, IONQ, QBTS, LAC
NASDAQ 100 Pre-Market Indicator: The NASDAQ 100 is down by 62.24 points to 24,595, with a total pre-market volume of 439,282,825 shares traded.
Most Active Stocks: Bitfarms Ltd. (BITF) and Artiva Biotherapeutics, Inc. (ARTV) are among the most active stocks, with BITF down to $5.01 and ARTV up to $5.63, both receiving "buy" recommendations.
Stock Performance Highlights: ProShares UltraPro Short QQQ (SQQQ) and IonQ, Inc. (IONQ) have shown notable movements, with SQQQ slightly up and IonQ reaching a 52-week high at $67.78.
Target Price Comparisons: NIO Inc. (NIO) is trading at 96.64% of its target price, while Lithium Americas Corp. (LAC) is at 129.2% of its target price, indicating varying performance against market expectations.
See More
U.S. Stocks Rise, AutoNation Shares Surge
- Market Performance: U.S. stocks traded higher midway through trading, with the S&P 500 gaining approximately 1.6%, the Dow rising 2.01% to 49,891.59, and the NASDAQ climbing 1.84% to 22,954.50, indicating a positive market sentiment and increased investor confidence.
- Sector Dynamics: Information technology shares gained 2.5% on Friday, while communication services stocks fell by 2%, reflecting a preference for tech stocks and concerns over the communication sector, which may impact future performance of related companies.
- AutoNation Earnings: Shares of AutoNation, Inc. (NYSE:AN) surged over 7% after posting fourth-quarter results, reporting adjusted earnings per share of $5.08, a 2% year-over-year increase that beat analyst expectations of $4.85, despite sales of $6.929 billion missing the consensus estimate of $7.200 billion, showcasing the company's resilience in profitability.
- Economic Indicators: The U.S. Manheim Used Vehicle Value Index rose 2.4% month-over-month in January, while the University of Michigan's consumer sentiment index increased by 0.9 points to 57.3, exceeding market estimates of 55, indicating a rebound in consumer confidence that could positively influence future spending.
See More
U.S. Stocks Rise in Morning Trading, Dow Jones Up Over 600 Points
- Strong Dow Performance: The Dow Jones index surged over 600 points on Friday, gaining 1.29% to close at 49,537.77, indicating a robust market rebound that may attract more investor interest.
- NASDAQ and S&P 500 Rise: The NASDAQ climbed 0.97% to 22,759.56, while the S&P 500 rose 1.02% to 6,867.68, reflecting a recovery trend in tech and other sectors, thereby boosting market confidence.
- Amazon's Earnings Impact Stock Price: Amazon.com Inc. (NASDAQ:AMZN) shares fell around 9% on Friday despite reporting fourth-quarter net sales of $213.39 billion, a 14% year-over-year increase; however, its earnings per share of $1.95 missed the consensus estimate of $1.97, leading to diminished investor confidence.
- Commodity Market Fluctuations: Oil prices dipped 0.3% to $63.08, while gold rose 1.6% to $4,969.10, indicating increased demand for safe-haven assets, and copper saw a slight increase of 0.4% to $5.8460, reflecting stable industrial demand.
See More
Carbon Revolution Faces Nasdaq Delisting
- Delisting Notification: Carbon Revolution plc received a notification from Nasdaq indicating that it will be delisted due to non-compliance with minimum shareholders' equity and failure to file its annual report, with trading suspension effective February 9, 2026, severely impacting the company's financing capabilities and market trust.
- Market Value Deficiency: The company's Market Value of Publicly Held Shares fell below $15 million over the last 30 trading days, and although there is a 180-day cure period, this opportunity is rendered moot by the delisting decision, likely leading to further declines in investor confidence.
- Compliance Failures: The company failed to provide sufficient information by January 30, 2026, to demonstrate its ability to complete a strategic transaction by May 5, 2026, indicating significant management shortcomings in compliance and financial transparency, which may hinder future financing and business development.
- Market Reaction: The delisting news is expected to severely impact Carbon Revolution's stock price, raising investor concerns about its future profitability and market position, further exacerbating the financial pressures the company faces.
See More
Ultragenyx Shares Plunge 42% Following Phase 3 Study Failures for Setrusumab
- Stock Plunge: Ultragenyx Pharmaceutical's shares fell sharply by 42% to $19.84 on Monday, primarily due to the failure of its Phase 3 Orbit and Cosmic studies for setrusumab (UX143) in Osteogenesis Imperfecta, leading to a significant decline in market confidence.
- Clinical Trial Failure: The results from Mereo BioPharma and Ultragenyx indicated that setrusumab did not achieve statistical significance in reducing the annualized clinical fracture rate, which not only impacts the company's short-term financial performance but may also have long-term negative implications for its future R&D investments and market competitiveness.
- Severe Market Reaction: The disappointing trial results raised investor concerns about Ultragenyx's future prospects, resulting in a substantial decrease in its market capitalization, reflecting the high sensitivity of investors to the success or failure of clinical trials in the biopharmaceutical sector.
- Industry Impact: Ultragenyx's failure could have a ripple effect across the biopharmaceutical industry, particularly in the bone metabolism disease space, as investors may adopt a more cautious approach towards similar product developments, potentially affecting financing and R&D strategies of related companies.
See More
Planet Labs Shares Rise Approximately 16%; Check Out 20 Stocks Making Moves in Premarket Trading
Planet Labs Performance: Planet Labs PBC shares surged 16.4% to $15.15 in pre-market trading after reporting third-quarter revenue of $81.25 million, exceeding analyst expectations, and raising its FY26 sales guidance.
Other Gainers: Several stocks saw significant pre-market gains, including Agape ATP Corporation (+152.3%), WORK Medical Technology Group (+38.4%), and Galaxy Payroll Group (+37.8%).
Notable Losers: Stocks that experienced sharp declines include Kaival Brands (-40%), Beasley Broadcast Group (-35.3%), and Oxford Industries (-25.6%) after reporting disappointing financial results.
Market Overview: The pre-market trading session showed a mix of gains and losses across various stocks, with notable movements influenced by recent earnings reports and guidance updates.
See More
Most Active Stocks in Pre-Market on October 17, 2025: BITF, SQQQ, ARTV, IONZ, TSLL, CREV, NIO, GWH, BBAI, IONQ, QBTS, LAC
NASDAQ 100 Pre-Market Indicator: The NASDAQ 100 is down by 62.24 points to 24,595, with a total pre-market volume of 439,282,825 shares traded.
Most Active Stocks: Bitfarms Ltd. (BITF) and Artiva Biotherapeutics, Inc. (ARTV) are among the most active stocks, with BITF down to $5.01 and ARTV up to $5.63, both receiving "buy" recommendations.
Stock Performance Highlights: ProShares UltraPro Short QQQ (SQQQ) and IonQ, Inc. (IONQ) have shown notable movements, with SQQQ slightly up and IonQ reaching a 52-week high at $67.78.
Target Price Comparisons: NIO Inc. (NIO) is trading at 96.64% of its target price, while Lithium Americas Corp. (LAC) is at 129.2% of its target price, indicating varying performance against market expectations.
See More
